Atara Biotherapeutics, Inc (ATRA) Covered Calls

You can sell covered calls on Atara Biotherapeutics, Inc to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for ATRA (prices last updated Fri 4:16 PM ET):

Atara Biotherapeutics, Inc (ATRA) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
15.13 -0.15 14.31 16.13 3.5M -7.7 0.7B
Covered Calls For Atara Biotherapeutics, Inc (ATRA)
Expiration Strike Call Bid Net Debit Return
If Flat
Return If Flat
Aug 16 15 1.45 14.68 2.2% 27.7%
Sep 20 15 2.10 14.03 6.9% 39.4%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial

Extended Business Description

Atara Biotherapeutics, Inc. is a clinical stage biopharmaceutical company focused on developing novel therapeutics for serious unmet medical needs, with an initial focus on muscle wasting conditions and oncology. Its product candidates are biologics targeting myostatin and activin, members of the transforming growth factor-beta, protein superfamily, which play roles in the growth and maintenance of muscle and many other body tissues. The company's product candidate includes PINTA 745, STM 434 and ATA 842. Atara Biotherapeutics was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in Brisbane, CA.